Saptak Chem Independent Director Chirag Nanavati Resigns from Board
Saptak Chem & Business Limited has announced the resignation of Independent Director Mr. Chirag Nanavati effective March 13, 2026, following BSE directive for regulatory compliance. Nanavati, who also served as Chairman of Audit and Stakeholder Relationship Committees, cited pre-occupation in other activities as the reason for resignation.

*this image is generated using AI for illustrative purposes only.
Saptak Chem & Business Limited has announced the resignation of its Independent Director Mr. Chirag Nanavati, effective March 13, 2026. The resignation was formally accepted during a board meeting held on the same date, as disclosed under Regulation 30 of SEBI listing regulations following BSE's directive dated March 14, 2026.
Board Meeting and Regulatory Compliance
The board meeting was conducted on March 13, 2026, from 4:30 p.m. to 5:00 p.m., where directors addressed key governance matters. The company submitted a fresh announcement to BSE Limited in compliance with SEBI Circular No: SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024.
| Meeting Parameter: | Details |
|---|---|
| Date: | March 13, 2026 |
| Duration: | 4:30 p.m. to 5:00 p.m. |
| Key Decision: | Acceptance of Independent Director resignation |
| Director Name: | Mr. Chirag Nanavati |
| DIN: | 08196966 |
| Scrip Code: | 506906 |
Committee Positions and Responsibilities
Mr. Nanavati held significant positions within the company's governance structure. His resignation encompasses multiple key roles including Chairman of the Audit Committee, Stakeholder Relationship Committee, and Member of the Nomination and Remuneration Committee.
| Position: | Role |
|---|---|
| Primary Role: | Independent Director |
| Audit Committee: | Chairman |
| Stakeholder Relationship Committee: | Chairman |
| Nomination and Remuneration Committee: | Member |
| Other Directorships: | Novyra Pharmachem Limited, Devrup Trading Limited |
Resignation Details and Confirmation
In his resignation letter dated March 13, 2026, Mr. Nanavati cited pre-occupation in other activities as the primary reason for stepping down. He expressed gratitude to the board for their cooperation during his tenure and wished the company continued success in future endeavors.
The director has confirmed that there are no material reasons for his resignation other than those mentioned in his resignation letter. Mr. Nanavati also holds directorships in two other listed entities: Novyra Pharmachem Limited and Devrup Trading Limited, both as Independent Director.
Corporate Governance Impact
The company has fulfilled its disclosure obligations by providing comprehensive details as required under SEBI regulations. The resignation represents a routine corporate governance change, with the company maintaining its commitment to regulatory transparency and proper board composition management. The company has requested Form DIR-12 to be filed with the Registrar of Companies for official record.



























